Cleared Traditional

K973198 - VGF-7 VASCULAR GRAFT FLOWMETER

K973198 is an FDA 510(k) clearance for VGF-7 VASCULAR GRAFT FLOWMETER, manufactured by Medicard , Ltd.. The device is a Class 2 Cardiovascular device with product code DPW cleared through the Traditional 510(k) pathway after a 414-day FDA review.

K973198 · Medicard , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1998
Decision
414d
Days
Class 2
Risk

K973198 is an FDA 510(k) clearance for the VGF-7 VASCULAR GRAFT FLOWMETER. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Medicard , Ltd. (North Attleboro, US). The FDA issued a Cleared decision on October 14, 1998 after a review of 414 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Medicard , Ltd. devices

FDA 510(k) Submission Details - K973198

510(k) Number K973198 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 26, 1997
Decision Date October 14, 1998
Days to Decision 414 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
289d slower than avg
Panel avg: 125d · This submission: 414d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPW Device Classification - Class 2, Special Controls

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 63
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K973198.
ROSSMAX AUTOMATIC WRISTWATCH BLOOD PRESSURE MONITOR, MODEL RM-4200
K992388 · Rossmax International , Ltd. · Aug 1999
WRIST BLOOD PRESSURE METER MODEL SE-330
K973078 · Sein Electronics Co., Ltd. · May 1999
TUBING BLOOD FLOW METER MODEL NUMBER HD-800
K982986 · Koven Technology, Inc. · Nov 1998
PERIFLUX SYSTEM 5000 MODULAR LASER DOPPLER SYSTEM MAIN UNIT MODEL PF 5001, INCLUDING PF 5010 LDPM UNIT
K974285 · Perimed, Inc. · May 1998
MICROLIFE MANUAL BLOOD PRESSURE MONITOR (MANUAL INFLATE) MODEL BP-2BIO
K970139 · Micro Weiss Electronics · Apr 1998
MICROLIFE AUTOMATIC BLOOD PRESSURE MONITOR
K970211 · Micro Weiss Electronics · Apr 1998